The GenNext Executive Team
Scot R Weinberger
President and CEO
Scot has over thirty years of industrial experience in pioneering and commercializing cutting-edge tools for life science research. Scot is a prolific inventor and holds 22 United States Patents for solutions in liquid chromatography, ultraviolet – visible spectrometry, capillary electrophoresis, time-of-flight mass spectrometry, matrix-assisted laser desorption/ionization, protein biochip technology, tandem mass spectrometry, and surface-tethered and free-solution label-free biosensors. He has authored over thirty scientific publications, 6 book chapters, and has over 2,000 citations in the areas of translational medicine, life science research, and technology development. As an entrepreneur, Scot has been in the founding teams of Linear Instruments, Linear Scientific, Biomolecular Separations, and Ciphergen Biosystems. More recently, he founded and launched Molecular Sensing and GenNext Technologies.
Dr. Joshua Sharp
Chief Technology Officer
Josh is a world renowned and internationally recognized expert in HRPF. He has over twenty-one peer-reviewed articles and has presented numerous invited lectures on the subject of biopharmaceutical HRPF. Josh is also an Associate Professor of Pharmacology and Research Professor of the Research Institute of Pharmaceutical Sciences at the University of Mississippi.
Dr. Ronald Orlando
Chief Science Officer
Ron is an internationally acclaimed expert in glycoprotein and HOS characterization. Ron’s entrepreneurial experience includes the founding of BioInquire and Glyco Scientific. In addition to being our company’s CSO, Ron is Editor-in-Chief of the Journal of Biomolecular Techniques and a Professor of Biochemistry and Molecular Biology at the University of Georgia.
Director of Software Engineering and Development
Bob has over 30 years’ experience of life science software development creating software solutions for: HPLC, HPCE, LCMS, MALDI-TOF, SELDI-TOF MS, FTICR, label-free biosensor (waveguide and interferometry), clinical diagnostics, and HOS analysis.
Director of Instrument Development
Jeffrey has over thirty years of life science industrial experience developing and commercializing products that utilize or perform interferometry (coherent and diffractive optics), opto-fluidics/biomedical instrument design, ophthalmics, medical imaging, laser surgery, and optical microlithography.
Director of Engineering
Christopher has more than three decades of experience developing promising new technologies to deliver value and ease-of-use to the customer. His experience spans biological devices, smart home devices, inkjet (small format, large format, photographic and multi-function) printers, digital cameras and LED lighting.
Dr. Emily Chea
Applied Research Scientist
Dr. Emily Chea received her PhD while studying with Professor Dr. Lisa Jones at the University of Maryland, Baltimore. Emily is a highly skilled research scientist in the use of LC-MS techniques for proteomics studies. Emily has made significant contributions to the development of FPOP and HRPF with particular emphasis towards in-cell FPOP (IC-FPOP). Emily focuses on utilizing IC-FPOP for proteome-wide structural biology to characterizing cellular drug–target interactions.
Discover the Benefits of HRPF
Accelerate biopharmaceutical and biosimilar development and protein conformational research.